64 research outputs found
Chronicles of Oklahoma
This article profiles Dollie York, Lucy Hargis, Grace Curtis, and Ruth Moore, itinerate preachers for the International Pentecostal Holiness Church (IPHC) who used the outdoors as their pulpit for saving souls
Deletion of genes encoding PU.1 and Spi-B in B cells impairs differentiation and induces pre-B cell acute lymphoblastic leukemia
The E26 transformation-specific (Ets) transcription factor PU.1 is required to generate lymphoid progenitor cells from hematopoietic stem cells, but it is not required to generate B cells from committed B-cell lineage progenitors.We hypothesized that PU.1 function in B-cell differentiation is complemented by the related Ets transcription factor Spi-B. To test this hypothesis, mice were generated lacking both PU.1 and Spi-B in the B-cell lineage. Unlike mice lacking PU.1 or Spi-B, mice deficient in both PU.1 and Spi-B in the B-cell lineage had reduced frequencies of B cells as well as impaired B-cell differentiation. Strikingly, all PU.1 and Spi-B-deficient mice developed pre-B cell acute lymphoblastic leukemia before 30 weeks of age. Pre-B cells accumulated in the thymus resulting in massive thymic enlargement and dyspnea. These findings demonstrate that PU.1 and Spi-B are essential transcriptional regulators of B-cell differentiation as well as novel tumor suppressors in the B-cell lineage. © 2011 by The American Society of Hematology
Navigating Work-Life Integration, Legal Issues, Patient Safety: Lessons for Work-Life Wellness in Academic Medicine: Part 1 of 3
In this series of three manuscripts, we will explore real-life scenarios encountered by clinicians, learners, and researchers in healthcare, which challenge our assumptions and our understanding of how to navigate issues as diverse as mental health, racial diversity, gender discrimination, imposter syndrome, and substance use disorder
Period and chemical evolution of SC stars
The SC and CS stars are thermal-pulsing AGB stars with C/O ratio close to
unity. Within this small group, the Mira variable BH Cru recently evolved from
spectral type SC (showing ZrO bands) to CS (showing weak C2). Wavelet analysis
shows that the spectral evolution was accompanied by a dramatic period
increase, from 420 to 540 days, indicating an expanding radius. The pulsation
amplitude also increased. Old photographic plates are used to establish that
the period before 1940 was around 490 days. Chemical models indicate that the
spectral changes were caused by a decrease in stellar temperature, related to
the increasing radius. There is no evidence for a change in C/O ratio. The
evolution in BH Cru is unlikely to be related to an on-going thermal pulse.
Periods of the other SC and CS stars, including nine new periods, are
determined. A second SC star, LX Cyg, also shows evidence for a large increase
in period, and one further star shows a period inconsistent with a previous
determination. Mira periods may be intrinsically unstable for C/O ~ 1; possibly
because of a feedback between the molecular opacities, pulsation amplitude, and
period. LRS spectra of 6 SC stars suggest a feature at wavelength > 15 micron,
which resembles one recently attributed to the iron-sulfide troilite. Chemical
models predict a large abundance of FeS in SC stars, in agreement with the
proposed association.Comment: 14 pages, 20 figures. MNRAS, 2004, accepted for publication. Janet
Mattei, one of the authors, died on 22 March, 2004. This paper is dedicated
to her memor
Characteristics and outcomes of patients with multiple myeloma at the Uganda Cancer Institute
Purpose: Data on multiple myeloma (MM) in sub-Sahara Africa is scarce.
In Uganda, there is a progressively increasing incidence of MM over the
years. Methods: We performed a retrospective study on 217 patients with
MM at the UCI using purposive sampling method. The objectives of the
study were to determine the clinical characteristics, treatment
outcomes, 5 year overall survival and predictors of survival of
patients with MM at the UCI from 01 January 2008 to 31 December 2012.
Results: There were 119 (54.8%) males; the mean(SD) age of the study
population at presentation was 59(12.8) years; 183(84.3%) patients
presented with bone pain, and 135 (61.9%) had skeletal pathology;
186(85.3%) were HIV negative, and 152(70%) had Durie-Salmon stage III.
The median overall survival was 2.5 years, (95% CI, 0.393-0.595);
factors significantly associated with worse survival were Durie-Salmon
stage III disease, HR=5.9, 95% CI (1.61 \u2013 21.74; P=0.007) and LDH
>225 U/L HR=3.3, 95% CI (0.57 \u2013 5.92; P=0.029). Conclusion:
Most patients with multiple myeloma at the UCI were diagnosed at a
relatively young age, presented with late stage disease and bone pain,
and had a shorter survival time. Factors associated with worse survival
were Durie-Salmon stage III and LDH >225 U/L
Who Invited You? The Complex Story Of Aquatic Invasive Species
Invasive species represent a global threat to ecosystems, human health, and the economy. A basic knowledge of invasive species biology is crucial to understand current and future impacts and implications. The purpose of this book is to provide a broad background on invasive species, and also details on specific examples through case studies.
The students in the course Aquatic Invasive Species (MAR 442) at the University of New England in Biddeford, Maine, have researched and reviewed scientific literature to educate readers about these issues. The class, comprised of fifteen junior and senior Marine Science, Marine Affairs, Animal Behavior, and Environmental Sciences students, selected the different topics, presented the material, wrote the chapters, and assembled the final versions into this book. This book cannot be all inclusive, but we think this book will provide an excellent broad overview of the most important aspects of Invasive Species Biology and might stimulate the reader to dive deeper into the material.https://dune.une.edu/marinesci_studproj/1003/thumbnail.jp
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
Background:
Glucagon-like peptide 1 receptor agonists differ in chemical structure, duration of action, and in their effects on clinical outcomes. The cardiovascular effects of once-weekly albiglutide in type 2 diabetes are unknown. We aimed to determine the safety and efficacy of albiglutide in preventing cardiovascular death, myocardial infarction, or stroke.
Methods:
We did a double-blind, randomised, placebo-controlled trial in 610 sites across 28 countries. We randomly assigned patients aged 40 years and older with type 2 diabetes and cardiovascular disease (at a 1:1 ratio) to groups that either received a subcutaneous injection of albiglutide (30–50 mg, based on glycaemic response and tolerability) or of a matched volume of placebo once a week, in addition to their standard care. Investigators used an interactive voice or web response system to obtain treatment assignment, and patients and all study investigators were masked to their treatment allocation. We hypothesised that albiglutide would be non-inferior to placebo for the primary outcome of the first occurrence of cardiovascular death, myocardial infarction, or stroke, which was assessed in the intention-to-treat population. If non-inferiority was confirmed by an upper limit of the 95% CI for a hazard ratio of less than 1·30, closed testing for superiority was prespecified. This study is registered with ClinicalTrials.gov, number NCT02465515.
Findings:
Patients were screened between July 1, 2015, and Nov 24, 2016. 10 793 patients were screened and 9463 participants were enrolled and randomly assigned to groups: 4731 patients were assigned to receive albiglutide and 4732 patients to receive placebo. On Nov 8, 2017, it was determined that 611 primary endpoints and a median follow-up of at least 1·5 years had accrued, and participants returned for a final visit and discontinuation from study treatment; the last patient visit was on March 12, 2018. These 9463 patients, the intention-to-treat population, were evaluated for a median duration of 1·6 years and were assessed for the primary outcome. The primary composite outcome occurred in 338 (7%) of 4731 patients at an incidence rate of 4·6 events per 100 person-years in the albiglutide group and in 428 (9%) of 4732 patients at an incidence rate of 5·9 events per 100 person-years in the placebo group (hazard ratio 0·78, 95% CI 0·68–0·90), which indicated that albiglutide was superior to placebo (p<0·0001 for non-inferiority; p=0·0006 for superiority). The incidence of acute pancreatitis (ten patients in the albiglutide group and seven patients in the placebo group), pancreatic cancer (six patients in the albiglutide group and five patients in the placebo group), medullary thyroid carcinoma (zero patients in both groups), and other serious adverse events did not differ between the two groups. There were three (<1%) deaths in the placebo group that were assessed by investigators, who were masked to study drug assignment, to be treatment-related and two (<1%) deaths in the albiglutide group.
Interpretation:
In patients with type 2 diabetes and cardiovascular disease, albiglutide was superior to placebo with respect to major adverse cardiovascular events. Evidence-based glucagon-like peptide 1 receptor agonists should therefore be considered as part of a comprehensive strategy to reduce the risk of cardiovascular events in patients with type 2 diabetes.
Funding:
GlaxoSmithKline
Recommended from our members
Elevated protein concentrations in newborn blood and the risks of autism spectrum disorder, and of social impairment, at age 10 years among infants born before the 28th week of gestation
Among the 1 of 10 children who are born preterm annually in the United States, 6% are born before the third trimester. Among children who survive birth before the 28th week of gestation, the risks of autism spectrum disorder (ASD) and non-autistic social impairment are severalfold higher than in the general population. We examined the relationship between top quartile inflammation-related protein concentrations among children born extremely preterm and ASD or, separately, a high score on the Social Responsiveness Scale (SRS total score ≥65) among those who did not meet ASD criteria, using information only from the subset of children whose DAS-II verbal or non-verbal IQ was ≥70, who were assessed for ASD, and who had proteins measured in blood collected on ≥2 days (N = 763). ASD (N = 36) assessed at age 10 years is associated with recurrent top quartile concentrations of inflammation-related proteins during the first post-natal month (e.g., SAA odds ratio (OR); 95% confidence interval (CI): 2.5; 1.2–5.3) and IL-6 (OR; 95% CI: 2.6; 1.03–6.4)). Top quartile concentrations of neurotrophic proteins appear to moderate the increased risk of ASD associated with repeated top quartile concentrations of inflammation-related proteins. High (top quartile) concentrations of SAA are associated with elevated risk of ASD (2.8; 1.2–6.7) when Ang-1 concentrations are below the top quartile, but not when Ang-1 concentrations are high (1.3; 0.3–5.8). Similarly, high concentrations of TNF-α are associated with heightened risk of SRS-defined social impairment (N = 130) (2.0; 1.1–3.8) when ANG-1 concentrations are not high, but not when ANG-1 concentrations are elevated (0.5; 0.1–4.2)
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
Tumor protein p53 (TP53) is the most frequently mutated gene in cancer1,2. In patients with myelodysplastic syndromes (MDS), TP53 mutations are associated with high-risk disease3,4, rapid transformation to acute myeloid leukemia (AML)5, resistance to conventional therapies6–8 and dismal outcomes9. Consistent with the tumor-suppressive role of TP53, patients harbor both mono- and biallelic mutations10. However, the biological and clinical implications of TP53 allelic state have not been fully investigated in MDS or any other cancer type. We analyzed 3,324 patients with MDS for TP53 mutations and allelic imbalances and delineated two subsets of patients with distinct phenotypes and outcomes. One-third of TP53-mutated patients had monoallelic mutations whereas two-thirds had multiple hits (multi-hit) consistent with biallelic targeting. Established associations with complex karyotype, few co-occurring mutations, high-risk presentation and poor outcomes were specific to multi-hit patients only. TP53 multi-hit state predicted risk of death and leukemic transformation independently of the Revised International Prognostic Scoring System (IPSS-R)11. Surprisingly, monoallelic patients did not differ from TP53 wild-type patients in outcomes and response to therapy. This study shows that consideration of TP53 allelic state is critical for diagnostic and prognostic precision in MDS as well as in future correlative studies of treatment response
Recommended from our members
Oklahoma Women Preachers, Pioneers, and Pentecostals: An Analysis of the Elements of Collective and Individual Ethos Within the Selected Writings of Women Preachers of the International Pentecostal Holiness Church
In this dissertation, I argue that ethos is generative as James Corder defines it. I seek to show that women preachers of the International Pentecostal Holiness Church who spent a significant amount of their careers in Oklahoma generated an ethos in their autobiographical texts and transcribed, edited interviews that constructed individualized as well as a social instantiations of ethos. I rhetorically analyzed these texts using five categories of ethos as a rubric for making connections between Corderian theory and my case studies: ethos as transformation, ethos as wisdom or authority, ethos in the stated motives and purposes in a text, ethos as charisma, and ethos as dynamic processes built from identification. In chapter one, I lay out my theoretical perspective, situating it within the canonical history of rhetoric. In chapter two, I describe the historical and religious contexts that put my study of women preachers into a wide conversation of views on women preachers and show how my work is a participation in and a continuation of such conversations. In chapter three, I focus on the autobiographical texts from the late nineteenth through the middle twentieth centuries, comparing male constructions of ethos to female from members of the same group. In chapter four, I make connections between the older texts of chapter three and the twenty-first century interviews I collected and transcribed in 2004 in order to demonstrate paradigm shifts that have occurred, as well as to show how new instantiations of ethos are grounded in localized histories as well as larger ones. In chapter five, I turn to a discussion of the nature of truth inside of epistemic rhetorics. Since generative ethos is aligned with epistemic rhetoric, how we construct ethos within a group is tied to our sense of the nature of truth. Particularly interesting is my connection of truth and ethos to the Holy Spirit
- …